DKCM
HUMA icon

Davidson Kempner Capital Management’s Humacyte HUMA Stock Holding History

Davidson Kempner Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-450,000
Closed -$1.28M – 302
2023
Q2 		$1.28M Buy
+450,000
New +$1.62M 0.02% 158

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Davidson Kempner Capital Management's HUMA Position: Q3 2023 in Review

Davidson Kempner Capital Management sold out of Humacyte (HUMA) in Q3 2023, closing a stake of 450,000 shares — an estimated $1.28M sold.

Davidson Kempner Capital Management first reported a position in HUMA in Q2 2023 and held it in 1 quarter. The position peaked at $1.28M in Q2 2023. 83 funds tracked by Wall St. Rank hold HUMA as of Q3 2023.

  • Davidson Kempner Capital Management reported no remaining Humacyte position as of Q3 2023 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 450,000 Humacyte shares in Q3 2023, an estimated $1.28M.
  • Davidson Kempner Capital Management first reported a position in Humacyte in Q2 2023 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Humacyte position peaked at $1.28M in Q2 2023.
  • 83 funds tracked by Wall St. Rank held Humacyte as of Q3 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.